Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast daily versus intermittent dosing versus placebo in episodic asthma in children aged 2 to 5 years
2006-002791-18Phase 4Completed
- Sponsor
- MSD Finland
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of montelukast in asthma and intermittent asthma (3 arms), sponsored by MSD Finland. Primary endpoint: Number of asthma episodes culminating in asthma attack. Started Aug 2006; status: completed.
02
Drugs
montelukast
03
Conditions
asthmaintermittent asthma
Beyond the preview
Go deeper on 2006-002791-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002791-18.